Records containing: Non-valvular Atrial Fibrillation
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-13Laminar Left Atrial Appendage Elimination (LAAX) Pivotal IDE Study
-
CLINICAL_TRIALS study record update · 2026-03-19Study of the Effects of Anticoagulant Interruption Covered by Percutaneous Left Atrial Occlusion in Patients With Chronic Atrial Fibrillation and Radiation Cystitis at Risk of Bleeding
-
CLINICAL_TRIALS study record update · 2026-02-13The CONFORMAL Early Feasibility Study An Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
-
CLINICAL_TRIALS study record update · 2025-09-17An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation
-
CLINICAL_TRIALS study record update · 2025-01-09Real-world Study on Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation in China
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-10-18Rivaroxaban Treatment Discontinuation Rates in Routine Clinical Practice in Italy in Patients With Non-valvular Atrial Fibrillation
-
CLINICAL_TRIALS study record update · 2024-09-24The Conformal Prague Study: An Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
-
CLINICAL_TRIALS study record update · 2024-08-12Observe the Safety and Effectiveness of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device for Subjects With Non-valvular Atrial Fibrillation to Reduce the Risk of Stroke in Hong Kong Area
-
CLINICAL_TRIALS study record update · 2024-07-11Safety and Effectiveness of Apixaban Compared to Warfarin in NVAF Patients at Higher Risk of Bleeding.
-
CLINICAL_TRIALS study record update · 2024-05-20Safety and Effectiveness of Apixaban in Very Elderly Patients With NVAF Compared to Warfarin Using Administrative Claims Data
-
CLINICAL_TRIALS study record update · 2024-04-23A Prospective, Multicenter, Non-randomized, Post-market Clinical Follow-up Study to Confirm Safety and Performance of the Coherex WaveCrest® Left Atrial Appendage Occlusion System in Patients With Non-valvular Atrial Fibrillation
-
CLINICAL_TRIALS study record update · 2024-01-11Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With NVAF With a History of Stroke or Transient Ischemic Attack - a Nationwide Retrospective Observational Study Using Claims Data in Japan
-
CLINICAL_TRIALS study record update · 2023-11-29A Prospective Exploratory Clinical Observation of Two Short-term Regimens (Dual Antiplatelet or Novel Oral Anticoagulant) for Subjects With Non-valvular Atrial Fibrillation After Left Atrial Appendage Occlusion by LAMax LAAC® Device
-
CLINICAL_TRIALS study record update · 2023-08-02Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - German Non-interventional Study (ENCOURAGE-AF)
-
CLINICAL_TRIALS study record update · 2023-06-12Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm (BOAT OAR)
-
CLINICAL_TRIALS study record update · 2022-12-19A Prospective, Multicenter Clinical Study of Percutaneous Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events in Patients With Atrial Fibrillation
-
CLINICAL_TRIALS study record update · 2022-06-30Investigating the Association of Type of Anticoagulation Treatment for Non-valvular Atrial Fibrillation and Risk of Bleeding in England
-
CLINICAL_TRIALS study record update · 2022-05-06A Prospective, Multicenter, Randomized, Active Controlled, Clinical Trial of the LAMax LAA Closure System Compared to the Watchman® LAAC Device for Subjects With Non-valvular Atrial Fibrillation to Reduce the Risk of Ischemic Stroke
-
CLINICAL_TRIALS study record update · 2022-03-31RIVA-PCI Registry - Prospective Registry of Rivaroxaban in Patients With Atrial Fibrillation
-
CLINICAL_TRIALS study record update · 2022-03-24Retrospective Study: Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
-
CLINICAL_TRIALS study record update · 2021-11-19Watchman FLX Left Atrial Appendage Closure Device Post Approval Study
-
CLINICAL_TRIALS study record update · 2021-07-26ClinicalTrials.gov study NCT02422602
-
CLINICAL_TRIALS study record update · 2020-12-10A Post-marketing Retrospective Non-interventional Study Using Nationwide Registries and Electronic Medical Records to Investigate the Real-life Effectiveness and Major Bleeding Complications of Oral Anticoagulants in Norwegian Non-valvular Atrial Fibrillation Patients
-
CLINICAL_TRIALS study record update · 2019-11-04SAFETY AND EFFECTIVENESS EVALUATION OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION TREATED WITH OACS: COMPARISON BETWEEN NOACS AND WARFARIN (CER3)
-
CLINICAL_TRIALS study record update · 2019-08-19Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)